TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06078865: FX Shoulder Prospective Clinical Study

Sponsor: FX Shoulder Solutions · Phase: PHASE2 · Area: IMMUNOLOGY · Target Enrollment: 600 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$11,040,000

Rescue Site Savings

+$7,279,500

Unlock Full NCT06078865 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06078865 Rescue Dossier →